Centaurus Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 1

Centaurus Therapeutics General Information

Description

Developer of new therapeutics designed to combat the metabolic underpinnings of chronic diseases. The company's therapeutics contain small molecule inhibitors of a highly-validated target in the ceramide biosynthesis pathway, for the treatment of NASH, dyslipidemia, type 2 diabetes, and other metabolic diseases, enabling patient to get therapeutic services and medicines to fight and cure orphan lipid storage diseases and fatty liver disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Primary Office
  • 8 The Green
  • Suite A
  • Dover, DE 19901
  • United States
+1 (302) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Centaurus Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 07-Apr-2015 Completed Startup
To view Centaurus Therapeutics’s complete valuation and funding history, request access »

Centaurus Therapeutics Patents

Centaurus Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2021510818-A Dynamic photodetection suppression system and how to use it Pending 11-Jan-2018 0000000000
AU-2019207887-A1 Inhibitors of dihydroceramide desaturase for treating disease Pending 11-Jan-2018 0000000000
US-20200339535-A1 Inhibitors of dihydroceramide desaturase for treating disease Pending 11-Jan-2018 0000000000
CA-3087729-A1 Inhibitors of dihydroceramide desaturase for treating disease Pending 11-Jan-2018 0000000000
EP-3737361-A4 Inhibitors of dihydroceramide desaturase for treating disease Pending 11-Jan-2018 C07D401/12 0

Centaurus Therapeutics Executive Team (2)

Name Title Board Seat Contact Info
Jeremy Blitzer Ph.D Co-Founder, Chief Strategy Officer & Board Member
Scott Summers Co-Founder & Scientific Advisor
To view Centaurus Therapeutics’s complete executive team members history, request access »

Centaurus Therapeutics Board Members (1)

Name Representing Role Since
Jeremy Blitzer Ph.D Centaurus Therapeutics Co-Founder, Chief Strategy Officer & Board Member 000 0000
To view Centaurus Therapeutics’s complete board members history, request access »

Centaurus Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Potrero Hill Therapeutics Venture Capital Minority 000 0000 000000 0
To view Centaurus Therapeutics’s complete investors history, request access »